New oxadiazole derivatives

作者: Riera Marta Carrascal , Pou Silvia Fonquerna , Juan Bernat Vidal , Martinez Lorena Taboada , Izquierdo Nuria Aguilar

DOI:

关键词:

摘要: The present invention relates to an oxadiazole derivative of formula (I)1 or a pharmaceutically acceptable salt N-oxide thereof: wherein, R 1 represents hydrogen atom, C 1-2 alkyl group 3-4 cycloalkyl-C group, both 2 and 3 represent group; atom b , cycloalkyl carboxy carbamoyl -CF c linear branched 2.5 substituted with one substituent selected from hydroxy triazolyl -P(O)(OH) -(CH )( )-C(O)OR' -NR'R" NR'R" )-NHC(O)R" ) (2-4) NH-(CH (1-3) -O-(CH (2-3) wherein: R' R" atom; 5-6 5- 6-membered saturated heterocyclic ring containing nitrogen carboxy(C alkyl) optionally by more substituents halogen atoms, groups, methyl amino groups groups; together the which they are attached form (a) 4 6 membered unsaturated contains, as heteroatom, N and, optionally, further is oxy (b) 5 heteroaryl atoms group.

参考文章(21)
Christian Schnell, Peter C. Hiestand, S1P receptor modulators for treating multiple sclerosis ,(2007)
Timothy L. Macdonald, Kevin R. Lynch, Method for treatment of neuropathic pain ,(2007)
Peter G. M. Wuts, Theodora W. Greene, Protective groups in organic synthesis ,(1981)
Andre Narodylo, Wolfgang Gottenauer, Anne H. de Boer, Joachim Goede, Coenraad Lerk, Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments ,(1996)
Henderik Willem Frijlink, Doetie Gjaltema, Paul Hagedoorn, Anne Haaije De Boer, Joachim Goede, Powder formulation disintegrating system and method for dry powder ,(2002)
Gilles Feutren, Robert Paul Hof, Volker Brinkmann, Use of S1P Receptor Agonists in Heart Diseases ,(2003)
Betty C. Soliven, Treatment of inflammatory diseases ,(2007)